Your Health, We Care
POETYK PSO-3 is a phase III randomized controlled study conducted in an Asian population with the use of Deucravacitinib. After continuous treatment with Deucravacitinib, the response rates to PASI 75 and PASI 90 were 68.8% and 38.2%, respectively, which were significantly better than the control group.
The latest 4-year follow-up results of the global Phase III long-term expansion trial POETYK PSO-LTE show a stable and increasing trend in all key efficacy indicators of deuteroxenib.
Scan code
Whatsapp
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
